Given the involvement of CHOP in DR5 upregulation and the contribution to sensitization development in TRAIL‐mediated apoptosis, we investigated whether dasatinib can affect CHOP‐dependent DR5 expression in GC, as well as the mechanism underlying dasatinib/TRAIL‐induced apoptosis. Here, TNFSF10 is linked to gastric cancer.